Yu-Ming Hsu

Title: Innovations of Yu-Ming Hsu in Cancer Treatment

Introduction

Yu-Ming Hsu is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 2 patents, his work showcases the intersection of natural products and medicinal chemistry.

Latest Patents

Yu-Ming Hsu's latest patents include innovative formulations aimed at combating cancer. One of his patents focuses on scalarane sesterterpenoids, which are extracted from specific sponge species. These compounds serve as inhibitors targeting topoisomerase II and Hsp90, providing a pharmaceutical composition for anticancer applications. Another patent details a method for preparing an n-hexane extract from the fruiting body of Antrodia cinnamomea, which contains valuable benzenoid compounds. This method not only enhances the extraction process but also allows for the detection of these compounds in healthcare products, highlighting their industrial value.

Career Highlights

Throughout his career, Yu-Ming Hsu has been associated with prestigious institutions such as National Dong Hwa University and Kaohsiung Medical University. His academic and research endeavors have significantly contributed to the advancement of pharmaceutical sciences.

Collaborations

Yu-Ming Hsu has collaborated with notable colleagues, including Mei-Chin Lu and Ying-Chi Du. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Yu-Ming Hsu's work exemplifies the vital role of innovation in the pharmaceutical industry, particularly in developing effective cancer treatments. His patents reflect a commitment to advancing medical science through research and collaboration.